KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Return on Sales (2016 - 2025)

Charles River Laboratories International has reported Return on Sales over the past 17 years, most recently at 0.28% for Q4 2025.

  • Quarterly results put Return on Sales at 0.28% for Q4 2025, down 6.0% from a year ago — trailing twelve months through Dec 2025 was 0.04% (down 4.0% YoY), and the annual figure for FY2025 was 0.04%, down 4.0%.
  • Return on Sales for Q4 2025 was 0.28% at Charles River Laboratories International, down from 0.06% in the prior quarter.
  • Over the last five years, Return on Sales for CRL hit a ceiling of 0.19% in Q4 2023 and a floor of 0.28% in Q4 2025.
  • Median Return on Sales over the past 5 years was 0.09% (2023), compared with a mean of 0.06%.
  • Biggest five-year swings in Return on Sales: grew 3bps in 2022 and later tumbled -40bps in 2024.
  • Charles River Laboratories International's Return on Sales stood at 0.15% in 2021, then rose by 11bps to 0.17% in 2022, then increased by 8bps to 0.19% in 2023, then crashed by -214bps to 0.21% in 2024, then crashed by -30bps to 0.28% in 2025.
  • The last three reported values for Return on Sales were 0.28% (Q4 2025), 0.06% (Q3 2025), and 0.05% (Q2 2025) per Business Quant data.